ValiRx (LON:VAL) Stock Price Up 24.3% – Time to Buy?
by Sarita Garza · The Markets DailyValiRx plc (LON:VAL – Get Free Report)’s share price rose 24.3% on Tuesday. The company traded as high as GBX 0.17 and last traded at GBX 0.17. Approximately 33,471,961 shares changed hands during trading, an increase of 153% from the average daily volume of 13,205,922 shares. The stock had previously closed at GBX 0.14.
ValiRx Trading Down 2.0%
The company has a market capitalization of £1.98 million, a price-to-earnings ratio of -0.37 and a beta of 0.59. The firm’s 50 day simple moving average is GBX 0.14 and its 200-day simple moving average is GBX 0.22.
ValiRx (LON:VAL – Get Free Report) last announced its quarterly earnings data on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative return on equity of 71.49% and a negative net margin of 6,548.06%. As a group, sell-side analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.